Reply to rituximab activity in CD20 positive multiple myeloma

被引：4
|
作者：
Gozzetti, A. [1 ]
Fabbri, A.
Lazzi, S.
Bocchia, M.
Lauria, F.
机构：
[1] Univ Siena, Dept Med & Immunol Sci, Div Hematol & Transplants, I-53100 Siena, Italy
[2] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
来源：
LEUKEMIA | 2007年 / 21卷 / 08期
关键词：
D O I：
10.1038/sj.leu.2404702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1842 / 1843
页数：2
相关论文
共 50 条
  • [1] Reply to Rituximab activity in CD20 positive multiple myeloma
    A Gozzetti
    A Fabbri
    S Lazzi
    M Bocchia
    F Lauria
    Leukemia, 2007, 21 : 1842 - 1843
  • [2] Rituximab in CD20 positive multiple myeloma
    J M Bergua
    C Cabrera
    E G Arteta
    J Prieto
    Leukemia, 2008, 22 : 1082 - 1083
  • [3] Rituximab in CD20 positive multiple myeloma
    Moreau, P.
    Voillat, L.
    Benboukher, L.
    Mathiot, C.
    Dumontet, C.
    Robillard, N.
    Herault, O.
    Garnache, F.
    Garand, R.
    Varoqueaux, N.
    Avet-Loiseau, H.
    Harousseau, J. L.
    Bataille, R.
    LEUKEMIA, 2007, 21 (04) : 835 - +
  • [4] Rituximab in CD20 positive multiple myeloma
    P Moreau
    L Voillat
    L Benboukher
    C Mathiot
    C Dumontet
    N Robillard
    O Hérault
    F Garnache
    R Garand
    N Varoqueaux
    H Avet-Loiseau
    J L Harousseau
    R Bataille
    Leukemia, 2007, 21 : 835 - 836
  • [5] Rituximab in CD20 positive multiple myeloma
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1082 - 1083
  • [6] Reply to 'Rituximab activity in CD20-positive multiple myeloma'
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1083 - 1084
  • [7] Reply to ‘Rituximab activity in CD20-positive multiple myeloma’
    A Gozzetti
    A Fabbri
    S Lazzi
    M Bocchia
    F Lauria
    Leukemia, 2008, 22 : 1083 - 1083
  • [8] Reply to ‘Rituximab in CD20 positive multiple myeloma’ by P Moreau et al.
    P T Greipp
    P Kapoor
    W G Morice
    T E Witzig
    P R Greipp
    Leukemia, 2008, 22 : 214 - 215
  • [9] Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al.
    Greipp, P. T.
    Kapoor, P.
    Morice, W. G.
    Witzig, T. E.
    Greipp, P. R.
    LEUKEMIA, 2008, 22 (01) : 214 - 215
  • [10] Rituximab in CD20 positive multiple myeloma: A prospective study from the IFM group.
    Moreau, Philippe
    Voillat, Laurent
    Benboubker, Lotfi
    Dumontet, Charles
    Mathiot, Claire
    Hulin, Cyrille
    Robillard, Nelly
    Loiseau, Herve Avet
    Herault, Olivier
    Garnache, Francine
    Varoqueaux, Nathalie
    Haroussead, Jean-Luc
    Bataille, Regis
    BLOOD, 2006, 108 (11) : 1021A - 1022A
12345